Drug:
Reaction: ANXIETY
20260101 - 20261231
No. 401 - 500
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 401 | 26914534 |
US |
65 | |
Recurrent cancer, Blood glucose increased, Anxiety, Stress, Incorrect product administration duration, |
||||
INSULIN LISPRO, INSULIN LISPRO, |
||||
| 402 | 26914554 |
GB |
38 | 2 |
Suicidal ideation, Anxiety, Drug interaction, |
||||
PREGABALIN, TIRZEPATIDE, SERTRALINE, QUETIAPINE, |
||||
| 403 | 26918137 |
59 | 2 | |
Pain in extremity, Ear pain, Dry throat, Sensation of foreign body, Parosmia, Anxiety, Somnolence, |
||||
MOMELOTINIB, |
||||
| 404 | 26918948 |
2 | ||
Dyspnoea, Anxiety, |
||||
ENTECAVIR, ENTECAVIR ANHYDROUS, FILGRASTIM-AAFI, FILGRASTIM-AAFI, FILGRASTIM-AAFI, |
||||
| 405 | 26904707 |
EU |
63 | 2 |
Suicidal ideation, Anxiety, Withdrawal syndrome, |
||||
ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, |
||||
| 406 | 26905015 |
BR |
2 | |
Hallucination, visual, Anxiety, Panic disorder, Disorientation, Hypertension, |
||||
ESKETAMINE HYDROCHLORIDE, |
||||
| 407 | 26905039 |
US |
69 | 2 |
Fatigue, Anxiety, |
||||
CLADRIBINE, |
||||
| 408 | 26905396 |
GB |
49 | 2 |
Depression, Drug interaction, Anxiety, Anxiety, Depressed mood, |
||||
ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, |
||||
| 409 | 26905477 |
US |
52 | 2 |
Discomfort, Blood pressure increased, Anxiety, Product use issue, Off label use, |
||||
ESKETAMINE HYDROCHLORIDE, THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE, |
||||
| 410 | 26905560 |
US |
1 | |
Blood glucose abnormal, Mood altered, Asthenia, Insomnia, Urine analysis abnormal, Anxiety, |
||||
ORAL SEMAGLUTIDE, |
||||
| 411 | 26905843 |
EU |
5 | 1 |
Personality change, Anxiety, Mood swings, Aggression, |
||||
MONTELUKAST, MONTELUKAST, |
||||
| 412 | 26905845 |
EU |
58 | 2 |
Breast abscess, Body temperature increased, Liver function test abnormal, Abdominal distension, Hunger, Sleep disorder, Weight loss poor, Anxiety, Stress, Motor dysfunction, Arthropathy, Hypersensitivity, Hordeolum, Diarrhoea, Anaemia, |
||||
SERTRALINE, ABEMACICLIB, LETROZOLE, LETROZOLE TABLETS, |
||||
| 413 | 26905850 |
US |
57 | 2 |
Mental disorder, Thyroid disorder, Anxiety, Hallucination, |
||||
TIRZEPATIDE, |
||||
| 414 | 26905928 |
US |
72 | |
Anxiety, Wrong technique in product usage process, |
||||
GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE, ROSUVASTATIN, TRIAMTERENE CAPSULES, TRIAMTERENE, HYDROCHLOROTHIAZIDE, |
||||
| 415 | 26905972 |
GB |
74 | 2 |
Weight increased, Anxiety, Abdominal pain, Asthenia, Balance disorder, Fatigue, |
||||
ZOLEDRONIC ACID, HYDROXOCOBALAMIN, OXYCODONE, METOCLOPRAMIDE, METOCLOPRAMIDE HYDROCHLORIDE, PANCRELIPASE, ACYCLOVIR, ESTRADIOL, |
||||
| 416 | 26906151 |
GB |
69 | 2 |
Anxiety, |
||||
ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, |
||||
| 417 | 26906235 |
GB |
51 | 2 |
Anxiety, Drug interaction, |
||||
MIRTAZAPINE, TIRZEPATIDE, |
||||
| 418 | 26906451 |
US |
2 | |
Chest pain, Back pain, Blood pressure increased, Gait disturbance, Hypoaesthesia, Drooling, Muscle spasms, Arthralgia, Hyperhidrosis, Anxiety, Walking aid user, |
||||
RAVULIZUMAB, |
||||
| 419 | 26906500 |
CO |
77 | 2 |
Memory impairment, COVID-19, Headache, Anxiety, Blister, Gastroenteritis viral, Psychiatric symptom, Pruritus, Urticaria, Illness, Bone disorder, Malaise, Cough, Gastrooesophageal reflux disease, Fall, Gait disturbance, Erythema, Dry skin, Angioedema, Swelling face, Peripheral swelling, Dyspnoea, Fatigue, Back pain, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, FEXOFENADINE, |
||||
| 420 | 26906528 |
CA |
60 | 1 |
Facial paralysis, Anxiety, Headache, Thirst, Dermatitis, Rash erythematous, Limb discomfort, Rash pruritic, Skin disorder, Hypoaesthesia, Condition aggravated, Off label use, |
||||
DURVALUMAB, DURVALUMAB, DURVALUMAB, APIXABAN, GABAPENTIN, METOCLOPRAMIDE, METOCLOPRAMIDE HYDROCHLORIDE, DUPILUMAB, |
||||
| 421 | 26906571 |
US |
41 | 2 |
Cardiac flutter, Speech disorder, Anxiety, Insomnia, Panic attack, Feeling abnormal, Headache, Palpitations, Dysarthria, Dysphemia, Aphasia, Fall, Product quality issue, |
||||
| 422 | 26906581 |
GB |
44 | 2 |
Panic attack, Anxiety, Drug interaction, Suicidal ideation, |
||||
FLUOXETINE HYDROCHLORIDE, FLUOXETINE, TIRZEPATIDE, |
||||
| 423 | 26906658 |
US |
2 | |
Surgery, Device breakage, Foreign body in urogenital tract, Complication of device removal, Embedded device, Anxiety, Pain, Abdominal pain lower, Pelvic pain, Muscle spasms, Menstrual disorder, Intermenstrual bleeding, Menstruation irregular, Abnormal uterine bleeding, Vaginal discharge, Device dislocation, |
||||
COPPER, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, LITHIUM CARBONATE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, |
||||
| 424 | 26906674 |
|||
Anxiety, Decreased appetite, Tremor, Headache, Nausea, Constipation, |
||||
ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, |
||||
| 425 | 26906686 |
GB |
27 | 2 |
Suicidal ideation, Drug interaction, Anxiety, |
||||
SERTRALINE, SERTRALINE, SERTRALINE, SERTRALINE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 426 | 26906858 |
GB |
24 | 2 |
Drug interaction, Anxiety, Panic attack, |
||||
MIRTAZAPINE, MIRTAZAPINE, MIRTAZAPINE, MIRTAZAPINE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 427 | 26906901 |
GB |
40 | 1 |
Drug interaction, Anxiety, |
||||
VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, |
||||
| 428 | 26906911 |
US |
85 | 1 |
Anxiety, Drug ineffective, Product dose omission issue, Inappropriate schedule of product administration, Extra dose administered, Product complaint, |
||||
FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, |
||||
| 429 | 26906978 |
GB |
32 | 2 |
Suicidal ideation, Drug interaction, Anxiety, |
||||
FLUOXETINE HYDROCHLORIDE, FLUOXETINE, TIRZEPATIDE, LISDEXAMFETAMINE DIMESYLATE, LISDEXAMFETAMINE, LISDEXAMFETAMINE DIMESYLATE CAPSULES, LISDEXAMFETAMINE DIMESYLATE, LISDEXAMFETAMINE, LISDEXAMFETAMINE DIMESYLATE CAPSULES, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, CLONIDINE, CLONIDINE, |
||||
| 430 | 26906979 |
GB |
52 | 2 |
Inappropriate schedule of product administration, Product dose omission issue, Product availability issue, Product complaint, Liver injury, Psoriatic arthropathy, Mental impairment, Memory impairment, Fibromyalgia, Eye disorder, Ear pain, Illness, Headache, Decreased appetite, Depressed mood, Tearfulness, Stress, Malaise, Pain, Anxiety, |
||||
METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, |
||||
| 431 | 26907085 |
US |
14 | 2 |
Anxiety, |
||||
DUPILUMAB, |
||||
| 432 | 26907177 |
US |
2 | |
Anxiety, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 433 | 26907320 |
US |
2 | |
Dyspnoea, Anxiety, Nausea, Pain, Off label use, |
||||
LEVOKETOCONAZOLE, CARIPRAZINE, BUSPIRONE HYDROCHLORIDE, |
||||
| 434 | 26907708 |
GB |
2 | |
Electric shock sensation, Migraine, Anxiety, Drug interaction, |
||||
ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, TIRZEPATIDE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, AMLODIPINE, LOSARTAN, |
||||
| 435 | 26907883 |
EU |
12 | 2 |
Hallucination, visual, Anxiety, Agitation, Restlessness, |
||||
ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, |
||||
| 436 | 26908067 |
CA |
2 | |
Anxiety, Palpitations, Tachycardia, Dizziness, Blood pressure increased, Paraesthesia, |
||||
VEDOLIZUMAB, MESALAMINE, AZATHIOPRINE, |
||||
| 437 | 26908070 |
GB |
31 | 2 |
Depression, Depressed mood, Fatigue, Anxiety, |
||||
CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, SERTRALINE, |
||||
| 438 | 26908188 |
GB |
22 | 2 |
Swelling face, Gingival swelling, Anxiety, Dysmenorrhoea, Sleep disorder, |
||||
SERTRALINE HYDROCHLORIDE, |
||||
| 439 | 26908213 |
US |
1 | |
Diarrhoea, Anxiety, |
||||
NERANDOMILAST, NINTEDANIB, |
||||
| 440 | 26908473 |
PA |
58 | 1 |
Rheumatoid factor, Prostatic specific antigen increased, Diverticulitis, Bradycardia, Urological examination abnormal, Weight decreased, Heat stroke, Choking, Anaphylactic reaction, Ill-defined disorder, Back pain, Memory impairment, Bladder discomfort, Dysuria, Hypoacusis, Conjunctivitis, Malaise, Sleep disorder, Muscle disorder, Fear, Visual impairment, Feeling abnormal, Somnolence, Pain, Lethargy, Fatigue, Blood urine present, Bacterial test positive, Urine abnormality, Asthenia, Tonsillitis, Infection, Anxiety, |
||||
CARBAMAZEPINE, AMLODIPINE, AMLODIPINE, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, FINGOLIMOD HCL, FINGOLIMOD HCL, FINGOLIMOD HCL, FINGOLIMOD HCL, FINGOLIMOD HCL, FINGOLIMOD HCL, OXYCODONE, SIMVASTATIN, FENOFIBRATE, |
||||
| 441 | 26908497 |
GB |
1 | |
Mood altered, Anxiety, Emotional disorder, |
||||
VANZACAFTOR, TEZACAFTOR, AND DEUTIVACAFTOR, |
||||
| 442 | 26908620 |
GB |
32 | 1 |
Anxiety, Panic attack, Drug interaction, Depression, Intrusive thoughts, |
||||
MIRTAZAPINE, ORAL SEMAGLUTIDE, PROPRANOLOL HYDROCHLORIDE, |
||||
| 443 | 26908688 |
US |
55 | 1 |
Psoriatic arthropathy, Blood pressure abnormal, Fibromyalgia, Nausea, Arthralgia, Injection site pain, Blood pressure increased, Injection site swelling, Fatigue, Depression, Incorrect dose administered, Headache, Anxiety, Dizziness, Spinal fusion surgery, Dysphagia, Dysphonia, |
||||
BIMEKIZUMAB, BIMEKIZUMAB, BIMEKIZUMAB, BIMEKIZUMAB, BIMEKIZUMAB, |
||||
| 444 | 26908754 |
CA |
40 | 2 |
Anxiety, Executive dysfunction, |
||||
LISDEXAMFETAMINE DIMESYLATE, LISDEXAMFETAMINE, LISDEXAMFETAMINE DIMESYLATE CAPSULES, SERTRALINE, LEVOTHYROXINE SODIUM, |
||||
| 445 | 26909127 |
US |
35 | 2 |
Chest pain, Chest discomfort, Vision blurred, Anxiety, |
||||
ORAL SEMAGLUTIDE, |
||||
| 446 | 26909177 |
US |
72 | 2 |
Heart rate irregular, Anxiety, Palpitations, Myalgia, |
||||
ROMOSOZUMAB-AQQG, CALCIUM, MAGNESIUM, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, ALIROCUMAB, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
| 447 | 26909256 |
2 | ||
Drug interaction, Anxiety, Sleep disorder, Nausea, Constipation, Eructation, |
||||
TIRZEPATIDE, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, |
||||
| 448 | 26909261 |
GB |
49 | 2 |
Anxiety, Peripheral coldness, Mouth ulceration, Reflux gastritis, Alopecia, Impaired gastric emptying, Constipation, |
||||
TIRZEPATIDE, PROPRANOLOL HYDROCHLORIDE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, SERTRALINE, FOLIC ACID, |
||||
| 449 | 26909435 |
27 | 2 | |
Tachycardia, Panic attack, Nervous system disorder, Nausea, Dizziness, Hyperhidrosis, Dyspnoea, Anxiety, |
||||
PREGABALIN, PREGABALIN, PREGABALIN, PREGABALIN, PREGABALIN, |
||||
| 450 | 26911997 |
|||
Anxiety, Mood altered, |
||||
ATOMOXETINE, |
||||
| 451 | 26912818 |
66 | 2 | |
Anxiety, Palpitations, Heart rate increased, Dyspnoea, |
||||
THYROID, PORCINE, THYROID, PORCINE, ROSUVASTATIN, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, ERGOCALCIFEROL, VITAMIN E, VITAMIN C, |
||||
| 452 | 26912826 |
|||
Suicidal ideation, Anxiety, |
||||
LISDEXAMFETAMINE DIMESYLATE, |
||||
| 453 | 26918010 |
27 | 2 | |
Anxiety, Depression, Loss of employment, Therapy cessation, |
||||
| 454 | 26904132 |
US |
2 | |
Therapeutic product effect decreased, Anxiety, |
||||
LUMATEPERONE, |
||||
| 455 | 26908760 |
76 | 2 | |
Fatigue, Muscular weakness, Anxiety, Irritability, Muscle spasms, Insomnia, Gait disturbance, |
||||
TERIPARATIDE, THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE, ERGOCALCIFEROL, PHYTONADIONE, |
||||
| 456 | 26902916 |
US |
47 | 2 |
Pruritus, Skin irritation, Scar, Stress, Anxiety, Sleep disorder due to a general medical condition, Injection site pain, |
||||
DUPILUMAB, |
||||
| 457 | 26903323 |
GB |
47 | 2 |
Depression, Anxiety, Fatigue, Insomnia, |
||||
FEXOFENADINE, FEXOFENADINE, |
||||
| 458 | 26903361 |
47 | 2 | |
Depression, Insomnia, Anxiety, Fatigue, |
||||
FEXOFENADINE, |
||||
| 459 | 26903637 |
GB |
1 | |
Anxiety, Panic attack, Depression, Crying, Akathisia, Tinnitus, |
||||
| 460 | 26917400 |
52 | 2 | |
Seizure, Anxiety, |
||||
LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, |
||||
| 461 | 26897599 |
US |
78 | 1 |
Psoriatic arthropathy, Anxiety, Insomnia, |
||||
APREMILAST, |
||||
| 462 | 26897608 |
GB |
49 | 2 |
Depressed mood, Anxiety, Drug interaction, |
||||
ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, |
||||
| 463 | 26897796 |
US |
36 | 2 |
Somnolence, Anxiety, Diarrhoea, |
||||
ZURANOLONE, |
||||
| 464 | 26897815 |
GB |
1 | |
Anxiety, Panic attack, Depression, Akathisia, Tinnitus, Crying, |
||||
TRAZODONE HYDROCHLORIDE, |
||||
| 465 | 26897888 |
US |
1 | |
Skin cancer, Squamous cell carcinoma, Precancerous condition, Thrombosis, Pulmonary embolism, Oesophageal stenosis, Barrett^s oesophagus, Mental impairment, Haemorrhage, Dry mouth, Skin infection, Pain, Diarrhoea, Dry throat, Dyspnoea exertional, Vomiting, Mobility decreased, Confusional state, Dyspnoea, Feeling abnormal, Arthropathy, Fatigue, Nausea, Arthralgia, Blood glucose abnormal, Breakthrough pain, Abdominal distension, Peripheral swelling, Tooth fracture, Pruritus, Hyperreflexia, Paraesthesia, Epistaxis, Skin ulcer, Musculoskeletal stiffness, Eating disorder, Early satiety, Pain of skin, Tooth disorder, Sensitive skin, Oral candidiasis, Dry eye, Oliguria, Mental status changes, Restless legs syndrome, Muscle twitching, Ocular hyperaemia, Weight increased, Contusion, Dizziness, Blood pressure increased, Headache, Feeling hot, Anxiety, Dysphagia, Full blood count abnormal, Myalgia, Abdominal discomfort, Depression, Polyp, Rib fracture, Memory impairment, Fall, Bone pain, Cystic lung disease, Aggression, Platelet count increased, Malaise, Insomnia, Irritability, Oral discomfort, Pulmonary mass, Hyperhidrosis, Vitamin D decreased, Skin exfoliation, Gastrooesophageal reflux disease, Balance disorder, Pigmentation disorder, Skin burning sensation, Tremor, Nervousness, Weight decreased, Dry skin, Impaired healing, Product dose omission issue, |
||||
RUXOLITINIB, RUXOLITINIB, RUXOLITINIB, RUXOLITINIB, RUXOLITINIB, RUXOLITINIB, RUXOLITINIB, RUXOLITINIB, RUXOLITINIB, RUXOLITINIB, RUXOLITINIB, RUXOLITINIB, RUXOLITINIB, RUXOLITINIB, RUXOLITINIB, RUXOLITINIB, RUXOLITINIB, RUXOLITINIB, RUXOLITINIB, RUXOLITINIB, RUXOLITINIB, AMOXICILLIN, HYDROXYUREA, CLOPIDOGREL, CLOPIDOGREL BISULFATE, CLOPIDOGREL, CLOPIDOGREL BISULFATE, MORPHINE SULFATE, RIVAROXABAN, METHOCARBAMOL, METHOCARBAMOL TABLETS, ALPRAZOLAM, SUCRALFATE, HYDROCHLOROTHIAZIDE, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, PAROXETINE, PAROXETINE HYDROCHLORIDE, PAROXETINE HYDROCHLORIDE HEMIHYDRATE, FOLIC ACID, MIRTAZAPINE, CLONAZEPAM, ERGOCALCIFEROL, BUPROPION, ERGOCALCIFEROL, GABAPENTIN, OXYCODONE HYDROCHLORIDE, TETRAHYDROZOLINE HYDROCHLORIDE, CYCLOSPORINE, |
||||
| 466 | 26897988 |
US |
2 | |
Dermatomyositis, Diarrhoea, Gastrointestinal disorder, Anxiety, White blood cell count decreased, Red blood cell count decreased, |
||||
OLAPARIB, ABEMACICLIB, |
||||
| 467 | 26898178 |
US |
2 | |
Subdural haematoma, Headache, Anxiety, Fear of injection, Therapy cessation, |
||||
| 468 | 26898261 |
US |
21 | 2 |
Malaise, Fatigue, Scarlet fever, Pyrexia, Pyelonephritis, Urinary tract infection, Myalgia, Anxiety, Metabolic acidosis, Hypomagnesaemia, Hyperparathyroidism secondary, Essential hypertension, Pulmonary hypertension, IgA nephropathy, Complications of transplanted kidney, Blood glucose increased, Mean cell haemoglobin decreased, |
||||
MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, CINACALCET, PREDNISONE, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, |
||||
| 469 | 26898405 |
US |
37 | 2 |
Anxiety, |
||||
OZANIMOD HYDROCHLORIDE, CALCIUM, |
||||
| 470 | 26898705 |
CA |
43 | |
Abdominal discomfort, Abdominal pain, Adjustment disorder with depressed mood, Alopecia, Amnesia, Anti-cyclic citrullinated peptide antibody positive, Anxiety, Arthralgia, Arthropathy, Asthenia, Blister, Blood cholesterol increased, Breast cancer stage III, Bursitis, C-reactive protein abnormal, Condition aggravated, Decreased appetite, Delirium, Depression, Diarrhoea, Discomfort, Dislocation of vertebra, Drug hypersensitivity, Drug intolerance, Dry mouth, Duodenal ulcer perforation, Dyspnoea, Ear pain, Fatigue, Fibromyalgia, Gait disturbance, General physical health deterioration, Glossodynia, Grip strength decreased, Hand deformity, Helicobacter infection, Hepatic enzyme increased, Hypertension, Hypoaesthesia, Intentional product use issue, Joint range of motion decreased, Live birth, Maternal exposure during pregnancy, Pemphigus, Pericarditis, Rash, Swelling, Synovitis, Systemic lupus erythematosus, Type 2 diabetes mellitus, Vomiting, Wheezing, Wound, Wound infection, Suspected off label use, Suspected off label use, Suspected off label use, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, INFLIXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, ERENUMAB-AOOE, ALENDRONATE SODIUM, ALENDRONATE SODIUM, CANDESARTAN, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, LAMOTRIGINE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, OXYCODONE HYDROCHLORIDE, OXYCODONE, QUETIAPINE FUMARATE, QUETIAPINE, RAMIPRIL, TOPIRAMATE, TOPIRAMATE, |
||||
| 471 | 26898985 |
BR |
68 | 2 |
Chronic obstructive pulmonary disease, Product use issue, Wrong technique in product usage process, Wrong technique in product usage process, Panic disorder, Oxygen saturation decreased, Vomiting, Malaise, Anxiety, Dyspnoea, Treatment noncompliance, Product availability issue, Device malfunction, |
||||
BECLOMETHASONE DIPROPIONATE/FORMOTEROL FUMARATE/GLYCOPYRROLATE, |
||||
| 472 | 26898997 |
CA |
43 | 2 |
Breast cancer stage II, Gait inability, Grip strength decreased, Infection, Memory impairment, Wound infection, Adjustment disorder with depressed mood, Amnesia, Anxiety, Asthenia, Asthma, Autoimmune disorder, Bursitis, C-reactive protein abnormal, Chest pain, Confusional state, Contusion, Deep vein thrombosis postoperative, Delirium, Depression, Dry mouth, Ear pain, Folliculitis, Incorrect route of product administration, Off label use, |
||||
DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, CELECOXIB, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, CALCIUM CARBONATE, CALCIUM CARBONATE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, INFLIXIMAB, INFLIXIMAB, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ADALIMUMAB-ADAZ, OXYCODONE, OXYCODONE HYDROCHLORIDE, OXYCODONE, SECUKINUMAB, SECUKINUMAB, |
||||
| 473 | 26899091 |
CA |
32 | 2 |
Pneumonia, Nasal congestion, Infection, Sinusitis, Sleep disorder due to a general medical condition, Vertigo, Urticaria, Vomiting, Rhinitis, Therapeutic product effect decreased, Nasopharyngitis, Decreased activity, Oropharyngeal pain, Stress, Dyspnoea exertional, Eczema, Feeding disorder, Psoriasis, Dizziness, Full blood count abnormal, Pain, Cough, Diarrhoea, Influenza, Tooth abscess, Ear infection, Drug ineffective, Product administration error, Asthma, Middle insomnia, Abdominal pain, Loss of personal independence in daily activities, Upper-airway cough syndrome, Wheezing, Productive cough, Migraine, Therapeutic response decreased, Blood pressure increased, Eosinophil count abnormal, Bacterial infection, Terminal insomnia, Dyspnoea, Anxiety, Fungal infection, Urinary tract infection, Musculoskeletal chest pain, Restrictive pulmonary disease, Nasal discharge discolouration, Emphysema, Forced expiratory volume decreased, Rales, Malaise, Tachycardia, Heart rate increased, Sleep disorder, Obstructive airways disorder, |
||||
FLUTICASONE PROPIONATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, IPRATROPIUM BROMIDE, SULFAMETHOXAZOLE AND TRIMETHOPRIM, MEPOLIZUMAB, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, OMALIZUMAB, |
||||
| 474 | 26899499 |
79 | 2 | |
Hypotension, Atrioventricular block, Sinus bradycardia, Anxiety, Drug intolerance, |
||||
LACOSAMIDE, LEVETIRACETAM, LEVETIRACETAM IN SODIUM CHLORIDE, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, ROPINIROLE, METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, |
||||
| 475 | 26899534 |
US |
||
Hyperthyroidism, Myoclonus, Anxiety, Product use in unapproved indication, |
||||
AMIODARONE HYDROCHLORIDE, |
||||
| 476 | 26899747 |
US |
66 | 1 |
Respiratory failure, Dyspnoea, Anxiety, Oxygen saturation decreased, |
||||
DUPILUMAB, |
||||
| 477 | 26899872 |
BR |
2 | |
Volvulus, Coma, Immunodeficiency, Immunodeficiency, Metastases to liver, Neutropenia, Metastases to pelvis, Liver injury, Bone lesion, Weight decreased, Breast cancer, Hypoaesthesia, Metastasis, Metastases to spine, Haemorrhage, Cataract, Dark circles under eyes, Wound, Carbohydrate antigen 15-3 increased, Dry skin, Nail disorder, Red blood cell count decreased, White blood cell count decreased, Drug hypersensitivity, Rash papular, Nausea, Nausea, Eye swelling, Vulvovaginal burning sensation, Illness, Alopecia, Oral discomfort, Eyelid disorder, Haematoma, Muscular weakness, Blood disorder, Skin disorder, Tumour marker decreased, Vitamin D decreased, Malaise, Blood test abnormal, Back pain, Musculoskeletal chest pain, Cardiac disorder, Pallor, Ill-defined disorder, Skin discolouration, Administration site pain, Blood creatinine abnormal, Erythema, Asthenia, Dizziness, Anxiety, Abdominal pain, Anaemia, Fatigue, Red blood cell count decreased, Pruritus, Hypotension, White blood cell count decreased, Abdominal pain upper, Somnolence, Skin discolouration, Visual impairment, Road traffic accident, Bone erosion, Labyrinthitis, Skeletal injury, Pain, Bone pain, Blood creatinine increased, Aspartate aminotransferase increased, Alanine aminotransferase increased, Somnolence, Somnolence, Somnolence, Blood urea increased, Chest pain, Platelet count decreased, Product dose omission issue, |
||||
FULVESTRANT, CAPECITABINE, CAPECITABINE, CAPECITABINE, CAPECITABINE, CAPECITABINE, ALPRAZOLAM, ALPRAZOLAM, LOSARTAN, AMLODIPINE, FULVESTRANT, FULVESTRANT, FULVESTRANT, FULVESTRANT, ANASTROZOLE, ONDANSETRON HYDROCHLORIDE, |
||||
| 478 | 26899873 |
CA |
36 | 1 |
Asthenia, Bruxism, Dysphonia, Hallucination, auditory, Overdose, Tendon disorder, Tooth disorder, Product use in unapproved indication, Toothache, Sexual dysfunction, Ear pain, Physical disability, Blood prolactin increased, Aggression, Hypoaesthesia, Mental disorder, Limb discomfort, Incoherent, Anxiety, Housebound, Screaming, Alexithymia, Impaired work ability, Ear disorder, Back disorder, Arthropathy, Impaired quality of life, Loss of employment, Hypotension, Libido disorder, Inappropriate schedule of product administration, Autism spectrum disorder, Tendonitis, Tongue movement disturbance, Dyskinesia, Speech disorder, Fatigue, Headache, Hallucination, Somnolence, Suicidal ideation, Aphonia, Product ineffective for unapproved use, |
||||
ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, CLONAZEPAM, CLOZAPINE, ARIPIPRAZOLE, ARIPIPRAZOLE, ARIPIPRAZOLE, ARIPIPRAZOLE, ARIPIPRAZOLE, ARIPIPRAZOLE, ARIPIPRAZOLE, ARIPIPRAZOLE, ARIPIPRAZOLE, ARIPIPRAZOLE, ARIPIPRAZOLE, PALIPERIDONE PALMITATE, PALIPERIDONE, LORAZEPAM, DIPHENHYDRAMINE HYDROCHLORIDE, CLOZAPINE, |
||||
| 479 | 26899895 |
US |
||
Serum ferritin decreased, Anxiety, Incorrect product administration duration, |
||||
LANSOPRAZOLE, |
||||
| 480 | 26899968 |
US |
1 | |
Anxiety, Agitation, Attention deficit hyperactivity disorder, |
||||
ASFOTASE ALFA, |
||||
| 481 | 26900005 |
CA |
80 | 1 |
Anxiety, Arterial occlusive disease, Balance disorder, Blood test abnormal, Body temperature decreased, Breath sounds abnormal, Chronic obstructive pulmonary disease, Contusion, Dizziness postural, Dyspnoea exertional, Gait disturbance, Hyperhidrosis, Insomnia, Lacrimal disorder, Limb discomfort, Lung neoplasm malignant, Musculoskeletal discomfort, Night sweats, Rales, Road traffic accident, Stress, Wheezing, Blood pressure systolic increased, Blood pressure increased, Pain, Discomfort, Hernia, Hernia pain, Hypersomnia, Lower respiratory tract infection, Weight decreased, Dizziness, Asthenia, Injection site swelling, Injection site pain, Injection site mass, Respiratory rate increased, Arthralgia, Cough, Depression, Malaise, Pneumonia, Fatigue, Dyspnoea, Diarrhoea, Abdominal pain, Product storage error, Needle issue, |
||||
METHOTREXATE, METHOTREXATE SODIUM, LEFLUNOMIDE, AMLODIPINE BESYLATE, OCTREOTIDE ACETATE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, FOLIC ACID, RISEDRONATE SODIUM, ALBUTEROL SULFATE, ALBUTEROL, TIOTROPIUM BROMIDE, |
||||
| 482 | 26900060 |
US |
9 | 1 |
Injection site pain, Anxiety, Crying, Muscle spasms, Injection site erythema, Injection site swelling, Injection site pruritus, |
||||
DUPILUMAB, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, |
||||
| 483 | 26900577 |
US |
||
Anxiety, |
||||
ELEXACAFTOR, TEZACAFTOR, AND IVACAFTOR, |
||||
| 484 | 26900849 |
US |
||
Fatigue, Depression, Anxiety, Dizziness, Weight increased, Bradycardia, Hypotension, Treatment noncompliance, Product use in unapproved indication, Product use issue, Off label use, |
||||
PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE, |
||||
| 485 | 26901005 |
US |
2 | |
Colectomy, Type 2 diabetes mellitus, Anxiety, Diarrhoea, Anal incontinence, Mobility decreased, Movement disorder, |
||||
PANCRELIPASE, PANCRELIPASE, |
||||
| 486 | 26901745 |
US |
59 | |
Eye operation, Pleural effusion, Dyspnoea, Dyspepsia, Anxiety, Energy increased, Decreased appetite, Weight decreased, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, RIOCIGUAT, FAMOTIDINE, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, RIVAROXABAN, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, ALBUTEROL SULFATE, LOSARTAN POTASSIUM, LOSARTAN, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, MELATONIN, FLUTICASONE PROPIONATE, ALBUTEROL SULFATE, ERGOCALCIFEROL, BUMETANIDE, SOTALOL HYDROCHLORIDE, OXYGEN, 0XYGEN, IRON, FOLIC ACID, |
||||
| 487 | 26901818 |
US |
80 | 2 |
Anxiety, Insomnia, |
||||
DUPILUMAB, |
||||
| 488 | 26901893 |
US |
1 | |
Tremor, Anxiety, Conjunctivitis, |
||||
LEBRIKIZUMAB-LBKZ, |
||||
| 489 | 26901961 |
1 | ||
Mesothelioma, Exposure to toxic agent, Pain, Anxiety, Injury, |
||||
TOLNAFTATE, |
||||
| 490 | 26902001 |
GB |
31 | |
Depression, Depressed mood, Anxiety, Fatigue, |
||||
CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, SERTRALINE, |
||||
| 491 | 26902017 |
US |
10 | 2 |
Weight decreased, Anxiety, |
||||
DUPILUMAB, |
||||
| 492 | 26902033 |
US |
58 | 2 |
Anxiety, Bacterial infection, Rash pruritic, Rash papular, Drug interaction, Biopsy, Blood glucose increased, Skin burning sensation, |
||||
SITAGLIPTIN PHOSPHATE, |
||||
| 493 | 26902219 |
GB |
24 | 2 |
Drug interaction, Anxiety, Panic attack, |
||||
TIRZEPATIDE, MIRTAZAPINE, |
||||
| 494 | 26902324 |
TR |
17 | 1 |
Suicide attempt, Toxicity to various agents, Intentional overdose, Intentional self-injury, Psychotic symptom, Major depression, Anxiety, Impulsive behaviour, Self esteem decreased, Mental disorder, Attention deficit hyperactivity disorder, |
||||
METHYLPHENIDATE HYDROCHLORIDE, METHYLPHENIDATE HYDROCHLORIDE, OLANZAPINE, SERTRALINE, |
||||
| 495 | 26902336 |
US |
27 | 2 |
Dizziness, Product storage error, Somnolence, Product dose omission issue, Anxiety, Dyspnoea, |
||||
SOTATERCEPT-CSRK, SOTATERCEPT-CSRK, SOTATERCEPT-CSRK, SOTATERCEPT-CSRK, SILDENAFIL CITRATE, SILDENAFIL, SILDENAFIL POWDER,, |
||||
| 496 | 26908266 |
72 | 2 | |
Toxicity to various agents, Abdominal pain, Asthenia, Dyspnoea, Anxiety, Hypophagia, Oedema peripheral, Crepitations, Rales, Wheezing, Hypoxia, Tachycardia, Hypotension, Acute respiratory failure, Cardio-respiratory arrest, |
||||
FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, OXALIPLATIN, TRASTUZUMAB, CARVEDILOL, EMPAGLIFLOZIN, FUROSEMIDE, PROCHLORPERAZINE, |
||||
| 497 | 26892133 |
US |
73 | 2 |
Hospitalisation, Hallucination, visual, Panic attack, Delusion, Anxiety, |
||||
PIMAVANSERIN TARTRATE, PIMAVANSERIN TARTRATE, QUETIAPINE, OXYBUTYNIN, PANTOPRAZOLE, PROPRANOLOL HYDROCHLORIDE, CALCIUM, BUPROPION, |
||||
| 498 | 26892211 |
CA |
41 | |
Malaise, Nervousness, Palpitations, Anxiety, Feeling of body temperature change, Flushing, |
||||
OMALIZUMAB, OMALIZUMAB, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, |
||||
| 499 | 26892267 |
US |
62 | 2 |
Blood glucose abnormal, Irritability, Depression, Anxiety, Fatigue, Malaise, |
||||
DULAGLUTIDE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 500 | 26892278 |
PR |
70 | 2 |
Anxiety, Pruritus, Incorrect route of product administration, |
||||
DUPILUMAB, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-07-30
